Muhammad Umair Mushtaq: Outcomes of Allo-HCT in MF Patients Aged 65 Years and Above

Muhammad Umair Mushtaq: Outcomes of Allo-HCT in MF Patients Aged 65 Years and Above

Muhammad Umair Mushtaq, Associate Professor of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center, shared a post on X about a paper he co-authored with colleagues, published in Clinical Lymphoma Myeloma and Leukemia:

“Outcomes of Allo-HCT in MF patients aged >65 years.”

Title: Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 65 Years and Above with Myelofibrosis

Journal: Clinical Lymphoma Myeloma and Leukemia

Authors: Moazzam Shahzad, Muhammad Kashif Amin, Sohaib Irfan, Rania Ahsan, Hana Qasim, Muhammad Jawad Javed, Matthew McGuirk, Sibgha Gull Chaudhary, Iqra Anwar, Abdulraheem Yacoub, Anurag K. Singh, Mehdi Hamadani, Joseph P. Mcguirk, Muhammad Umair Mushtaq

Read the full article.

Allo-HCT

More posts featuring Muhammad Umair Mushtaq on OncoDaily.